Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis
Completed · Phase 4
Conditions studied: Ankylosing Spondylitis
In brief
This was a study estimating the clinical difference between 300 mg and 150 mg of secukinumab following dose escalation to 300 mg in patients with ankylosing spondylitis
Key facts
- Study ID
- NCT03350815
- Run by
- Novartis Pharmaceuticals
- People needed
- 322
- Starts
- 2018-03-13
- Expected to finish
- 2021-05-29
- Last updated by the study team
- 2022-04-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Fullerton, California, United States
- Novartis Investigative Site — Loma Linda, California, United States
- Novartis Investigative Site — Palm Desert, California, United States
- Novartis Investigative Site — Tustin, California, United States
- Novartis Investigative Site — Upland, California, United States
- Novartis Investigative Site — Aventura, Florida, United States
- Novartis Investigative Site — Boca Raton, Florida, United States
- Novartis Investigative Site — Brandon, Florida, United States
- Novartis Investigative Site — DeLand, Florida, United States
- Novartis Investigative Site — Gainesville, Florida, United States
- Novartis Investigative Site — Orlando, Florida, United States
- Novartis Investigative Site — Plantation, Florida, United States
- Novartis Investigative Site — St. Petersburg, Florida, United States
- Novartis Investigative Site — Tamarac, Florida, United States
- Novartis Investigative Site — Tampa, Florida, United States
- Novartis Investigative Site — Zephyrhills, Florida, United States
- Novartis Investigative Site — Duluth, Georgia, United States
- Novartis Investigative Site — Springfield, Illinois, United States
- Novartis Investigative Site — Vernon Hills, Illinois, United States
- Novartis Investigative Site — Evansville, Indiana, United States
- Novartis Investigative Site — Monroe, Louisiana, United States
- Novartis Investigative Site — Cumberland, Maryland, United States
- Novartis Investigative Site — Hagerstown, Maryland, United States
- Novartis Investigative Site — Wheaton, Maryland, United States
- Novartis Investigative Site — Jonesboro, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.